↓ Skip to main content

Targeting Alpha-Synuclein as a Therapy for Parkinson’s Disease

Overview of attention for article published in Frontiers in Molecular Neuroscience, December 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Citations

dimensions_citation
224 Dimensions

Readers on

mendeley
494 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Targeting Alpha-Synuclein as a Therapy for Parkinson’s Disease
Published in
Frontiers in Molecular Neuroscience, December 2019
DOI 10.3389/fnmol.2019.00299
Pubmed ID
Authors

Carroll Rutherford Fields, Nora Bengoa-Vergniory, Richard Wade-Martins

X Demographics

X Demographics

The data shown below were collected from the profiles of 29 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 494 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 494 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 69 14%
Student > Bachelor 68 14%
Researcher 56 11%
Student > Master 52 11%
Student > Doctoral Student 23 5%
Other 40 8%
Unknown 186 38%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 95 19%
Neuroscience 70 14%
Pharmacology, Toxicology and Pharmaceutical Science 28 6%
Chemistry 25 5%
Medicine and Dentistry 23 5%
Other 50 10%
Unknown 203 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 32. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 September 2022.
All research outputs
#1,252,562
of 26,017,215 outputs
Outputs from Frontiers in Molecular Neuroscience
#86
of 3,372 outputs
Outputs of similar age
#29,887
of 481,775 outputs
Outputs of similar age from Frontiers in Molecular Neuroscience
#2
of 69 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,372 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 481,775 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 69 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.